Article
Mutations in the Na(+)/citrate cotransporter NaCT (SLC13A5) in pediatric patients with epilepsy and developmental delay.
Molecular medicine (Cambridge, Mass.) - 26 May 2016
Klotz Jenna, Porter Brenda E, Colas Claire, Schlessinger Avner, Pajor Ana M
Abstract excerpt
Mutations in the SLC13A5 gene that codes for the Na(+)/citrate cotransporter, NaCT, are associated with early onset epilepsy, developmental delay and tooth dysplasia in children. In the present study we identify additional SLC13A5 mutations in nine epilepsy patients from six families. To better characterize the syndrome, families with affected children answered questions about the scope of illness and treatment...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
